Tenax Therapeutics
Tenax Therapeutics enrolls first patient in phase 3 trial for pulmonary hypertension treatment
February 8, 2024Research and Development Cardiology, Tenax Therapeutics, clinical trial, pulmonary hypertension
Tenax Therapeutics has announced that it has enrolled the first patient in its phase 3 LEVEL study, which aims to …
Latest content
October 28, 2026
Acumetis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
